Assignee
GH RES IRELAND LIMITED
IE·3 granted patents·30 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
33 records- 0176US2024108602A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0276US2024108601A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0376US2024115549A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0476US2024115550A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0574US12172960B2Organic compound saltsGH RES IRELAND LIMITED·Filed 2024·Granted Dec 24, 2024·0 cites·22 claims
- 0674US2025213528A15-methoxy-n,n-dimethyltryptamine for the treatment of anxietyGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0774US2025235427A15-methoxy-n,n-dimethyltryptamine for the treatment of social/emotional withdrawal or detachmentGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0874US2025241895A15-meo-dmt for use in the treatment of sleep disturbanceGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 0974US2025205256A15-meo-dmt for use in the treatment of negative thinkingGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1074US2025170099A1Treatment of postnatal depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1174US2025213531A15-meo-dtm for the treatment of bipolar disorderGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1274US2025241891A1Treatment of anxietyGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1374US2025241892A15-methoxy-n,n-dimethyltryptamine for the treatment of psychomotor retardationGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1474US2025241893A1Treatment of cognitive dysfunctionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1574US2025213529A15-methoxy-n.n-dimethyltryptamine for the treatment of psychomotor retardationGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1674US2025205199A15-methoxy-n,n-dimethyltryptamine for the treatment of social/emotional withdrawal or detachmentGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1774US2025213533A15-meo-dmt for use in the treatment of sleep disturbanceGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1874US2025213532A15-methoxy-n,n-dimethyltryptamine for the treatment of bipolar disorderGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 1974US2025213530A15-meo-dmt for use in the treatment of negative thinkingGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2074US2025213534A15-methoxy-n,n-dimethyltryptamine for the treatment of cognitive dysfunctionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2169US2025188029A1Organic compound saltsGH RES IRELAND LIMITED·Filed 2024·Application pending·0 cites
- 2261US2024307350A15-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating depressionGH RES IRELAND LIMITED·Filed 2024·Application pending·0 cites
- 2361US2025134861A1Compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for use in treating mental disordersGH RES IRELAND LIMITED·Filed 2024·Application pending·0 cites
- 2456US2024327346A1Method for preparing a tryptamine derivativeGH RES IRELAND LIMITED·Filed 2022·Application pending·0 cites
- 2550US2025205200A15-methoxy-n,n-dimethyltryptamine for the treatment of postpartum depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2650US2025241894A1Treatment of mental disordersGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2750US2025221963A15-meo-dmt for use in the treatment of postpartum depressionGH RES IRELAND LIMITED·Filed 2023·Application pending·0 cites
- 2845US2022031662A1Compositions comprising 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for use in treating mental disordersGH RES IRELAND LIMITED·Filed 2020·Application pending·0 cites
- 2945US2022071958A15-methoxy-n,n-dimethyltryptamine (5-meo-dmt) for treating depressionGH RES IRELAND LIMITED·Filed 2020·Application pending·0 cites
- 3042US2023075124A1Aerosol comprising 5-methoxy-n,n-dimethyltryptamineGH RES IRELAND LIMITED·Filed 2021·Application pending·0 cites
- 3141US2022324802A1Method for purifying an organic compoundGH RES IRELAND LIMITED·Filed 2020·Application pending·0 cites
- 3229USD1102882SConnect elementGH RES IRELAND LIMITED·Filed 2023·Granted Nov 25, 2025·0 cites·1 claims
- 3325USD1115039SDrug cartridge housingGH RES IRELAND LIMITED·Filed 2023·Granted Feb 24, 2026·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when GH RES IRELAND LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →